Helicos Biosciences, (NASDAQ: [[ticker:HLCS]]) the Cambridge, MA-based maker of genetic analysis tools, said it has hired Ronald Lowy as CEO, replacing Steve Lombardi, who was promoted to the top job in August. Lombardi will continue working at the company as president and as a member of the board, while concentrating on commercializing the HeliScope product line, the company said in a statement. Lowy, who joined the Helicos board in November 2007, is the former CEO of Fisher Biosciences, a division of Fisher Scientific. (Update: Helicos said Lowy will perform his CEO duties on a part-time basis, according to a regulatory filing issued later in the day.)
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
